Skip to content
EntityQ12747348· pop 7· linked from 36 articles

vestipitant

Sign in to save

Also known as GW597588B

Vestipitant (INN) is a drug developed by GlaxoSmithKline which acts as a selective antagonist for the NK1 receptor. It is under development as a potential antiemetic and anxiolytic drug, and as a treatment for tinnitus and insomnia.

Wikidata facts

Mass
491.18076
Show 4 more facts
chemical formula
C₂₃H₂₄F₇N₃O
isomeric SMILES
CC1=C(C=CC(=C1)F)[C@H]2CNCCN2C(=O)N(C)[C@H](C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F
canonical SMILES
CC1=C(C=CC(=C1)F)C2CNCCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F
Commons category
Vestipitant
Sources (4)

via Wikidata · CC0

~2 min read

Article

2 sections
Contents
  • See also
  • References

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 399133414 | IUPAC_name = (2S)-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methylpiperazine-1-carboxamide | image = Vestipitant structure.svg | image_class = skin-invert-image | width = 225

| tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US =

Available in 6 languages

via Wikidata sitelinks · CC0

Connections

Categories